PROFUND ADVISORS LLC

Position in MNKD — Mannkind Corp

CIK 1129919 BETHESDA, MD

Position in MNKD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$517,726

-$116,699 QoQ

Shares Held

121,532

-53.1% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#85

of 254 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. MNKD ranks #91 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$517,726	121,532	-53.1%	Shares	Sole	2026-08-11
2026-03-31	$634,425	258,949	+53.2%	Shares	Sole	2026-04-27
2025-12-31	$958,235	169,001	+246.5%	Shares	Sole	2026-02-06
2025-09-30	$261,937	48,778	-6.7%	Shares	Sole	2025-11-06
2025-06-30	$195,523	52,279	-8.7%	Shares	Sole	2025-08-07
2025-03-31	$287,962	57,249	-9.5%	Shares	Sole	2025-05-08
2024-12-31	$406,646	63,242	-2.8%	Shares	Sole	2025-02-14
2024-09-30	$409,139	65,046	-3.6%	Shares	Sole	2024-11-14
2024-06-30	$352,329	67,496	-42.1%	Shares	Sole	2024-08-13
2024-03-31	$528,098	116,578	-13.8%	Shares	Sole	2024-05-08
2023-12-31	$492,397	135,274	-7.3%	Shares	Sole	2024-02-14
2023-09-30	$602,695	145,931	-32.3%	Shares	Sole	2023-11-13
2023-06-30	$876,710	215,408	-16.0%	Shares	Sole	2023-08-10
2023-03-31	$1,050,801	256,293	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.